602. Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons.
作者: Andrew H Karaba.;Camille Hage.;Isabella Sengsouk.;Prasanthy Balasubramanian.;Dorry L Segev.;Aaron A A R Tobian.;William A Werbel.
来源: JAMA. 2025年333卷5期429-432页 615. Predatory Journals: What Can We Do to Protect Their Prey?
作者: Christine Laine.;Dianne Babski.;Vivienne C Bachelet.;Till W Bärnighausen.;Christopher Baethge.;Kirsten Bibbins-Domingo.;Frank Frizelle.;Laragh Gollogy.;Sabine Kleinert.;Elizabeth Loder.;João Monteiro.;Eric J Rubin.;Peush Sahni.;Christina C Wee.;Jin-Hong Yoo.;Lilia Zakhama.
来源: JAMA. 2025年333卷9期761-762页 618. Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial.
作者: Doortje Rademaker.;Leon de Wit.;Ruben G Duijnhoven.;Daphne N Voormolen.;Ben Willem Mol.;Arie Franx.;J Hans DeVries.;Rebecca C Painter.;Bas B van Rijn.; .;Sarah E Siegelaar.;Bettina M C Akerboom.;Rosalie M Kiewiet-Kemper.;Marion A L Verwij-Didden.;Fahima Assouiki.;Simone M Kuppens.;Mirjam M Oosterwerff.;Eva Stekkinger.;Mattheus J M Diekman.;Tatjana E Vogelvang.;Gerdien Belle-van Meerkerk.;Sander Galjaard.;Koen Verdonk.;Annemiek Lub.;Tamira K Klooker.;Ineke Krabbendam.;Jeroen P H van Wijk.;Anjoke J M Huisjes.;Thomas van Bemmel.;Remco G W Nijman.;Annewieke W van den Beld.;Wietske Hermes.;Solrun Johannsson-Vidarsdottir.;Anneke G Vlug.;Remke C Dullemond.;Henrique J Jansen.;Marieke Sueters.;Eelco J P de Koning.;Judith O E H van Laar.;Pleun Wouters-van Poppel.;Inge M Evers.;Marina E Sanson-van Praag.;Eline S van den Akker.;Catherine B Brouwer.;Brenda B Hermsen.;Ralph Scholten.;Rick I Meijer.;Marsha van Leeuwen.;Johanna A M Wijbenga.;Lia D E Wijnberger.;Arianne C van Bon.;Flip W van der Made.;Silvia A Eskes.;Mirjam Zandstra.;William H van Houtum.;Babette A M Braams-Lisman.;Catharina R G M Daemen-Gubbels.;Janna W Nijkamp.;Harold W de Valk.;Maurice G A J Wouters.;Richard G IJzerman.;Irwin Reiss.;Joris A M van der Post.;Judith E Bosmans.
来源: JAMA. 2025年333卷6期470-478页
Metformin and glyburide monotherapy are used as alternatives to insulin in managing gestational diabetes. Whether a sequential strategy of these oral agents results in noninferior perinatal outcomes compared with insulin alone is unknown.
|